Welspun Investments & Commercials has approved the divestment of up to 67.58 lakh equity shares in Welspun Corp Limited. The board set a floor price of ₹2,250 per share for the transaction.

The decision was taken during the board meeting held on August 25, 2026. The company stated it will provide further disclosures upon completion of the sale.

Transaction Details

The board authorized the sale pursuant to Regulation 30 of the SEBI Listing Regulations. The meeting commenced at 4:15 pm and concluded at 5:00 pm.

Regulatory Compliance

The disclosure was made in accordance with the company’s policy for determining the materiality of events and information. No financial impact or proceeds from the transaction were disclosed in the filing.

Welspun Investments and Commercials reported a narrowed net loss of ₹14.88 lakh for the quarter ended June 30, 2026, down from a loss of ₹20.24 lakh in the corresponding period of FY25. The improvement was driven by higher revenue from operations and lower expenses, although the company’s core operations remained unprofitable. The Board of Directors approved the unaudited financial results on August 04, 2026, following review by the Audit Committee.

Total revenue from operations increased to ₹12.75 lakh in Q1FY27, up from ₹3.96 lakh in Q1FY25. This growth was led by interest income of ₹12.16 lakh and net gains on fair value changes of ₹0.59 lakh. Other income contributed ₹0.40 lakh. Total expenses decreased to ₹27.95 lakh from ₹23.63 lakh in the prior year quarter, with employee benefit expenses at ₹20.99 lakh and other expenses at ₹6.96 lakh.

The company incurred a profit before tax loss of ₹14.80 lakh. Tax expense was a credit of ₹0.08 lakh due to deferred tax benefits. Consequently, the basic earnings per share (EPS) were a loss of ₹0.41, compared to a loss of ₹0.55 per share in Q1FY25. The trading window for insiders re-opened on August 07, 2026.

Financial Performance Highlights

What the Numbers Show

While the operating loss narrowed modestly, the most significant movement in the financials was in Other Comprehensive Income (OCI). OCI surged to ₹48,636.68 lakh in Q1FY27, compared to ₹5,527.44 lakh in Q1FY25. This increase was primarily driven by a change in the fair valuation of equity instruments, which recorded a gain of ₹56,752.25 lakh before tax effects. This substantial unrealized gain highlights the company’s exposure to market valuation fluctuations in its investment portfolio, as it operates as a non-deposit taking Core Investment Company (CIC) without subsidiaries or joint ventures.

The statutory auditors, C N K & Associates LLP, issued a limited review report pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The comparative figures for Q1FY25 were reviewed by the erstwhile auditors, P Y S & Co LLP. The company’s paid-up equity share capital remains at ₹365.45 lakh.